Abstract:Background: Domestic and international guidelines recommend endoscopic resection for stage T1 colorectal adenocarcinoma with indications. However, completion surgery remains imperative for patients exhibiting high-risk factors subsequent to endoscopic procedures. Objective: To investigate the evidence, pathological features, and surgical outcomes of completion surgery in patients with T1 colorectal adenocarcinoma following endoscopic resection. Methods: We retrospectively collect data on the clinical features and treatment outcomes of patients with stage T1 colorectal adenocarcinoma who underwent endoscopic resection followed by surgical resection and those who initially completed surgical intervention at Peking University International Hospital between January 2019 and October 2022, with the aim of assessing the necessity and feasibility of surgical intervention. Results: Seventeen patients (Group A) with high-risk factors following endoscopic procedure, especially with deep submucosal invasion and vascular or lymphatic invasion, experienced further surgical resection. The median interval between endoscopic resection and completion surgery was 23.71 days ± 15.89. Sixteen patients (Group B) underwent radical resection without any prior interventions. The surgical approach involves integration of laparoscopy and colonoscopy for precise localization and quantitative diagnosis, followed by radical surgery. The two groups demonstrated significant differences statistically with reference to tumor diameter (1.65 cm ± 0.77 vs 3.36 cm ± 1.39, P = 0.000) and the attainment of standard lymph node count (cases of detected lymph nodes larger than or equal to 12, 5 vs 12, P = 0.015). Postoperative complications and hospital stay manifested no significant disparity statistically in two groups. Patients who underwent completion surgery had no inferior outcomes compared with those who underwent direct surgery in terms of 5-year disease-free survival (Log rank test: P = 0.083, Breslow test: P = 0.089). The two groups also exhibited no significant differences statistically in the context of overall survival (Log rank test: P = 0.652, Breslow test: P = 0.758). Conclusion: Completion surgery is a safe and feasible treatment option for T1 colorectal adenocarcinoma patients with high-risk factors, particularly those with deep submucosal invasion and vascular or lymphatic invasion following endoscopic treatment. Furthermore, subsequent treatment should be chosen based on a comprehensive analysis of the patient's history of abdominal surgery, willingness, and pathological features.

A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection

The Risk of Metastatic Recurrence after Non-Curative Endoscopic Resection with Negative Deep Margins for Early Colorectal Cancer: Two-Center Retrospective Cohort Study

How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma?

Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.

Risk Factors for Lymph Node Metastasis in Submucosally Invasive Colorectal Cancer

Refining Risk Criteria May Substantially Reduce Unnecessary Additional Surgeries after Local Resection of T1 Colorectal Cancer

Identifying timing and risk factors for early recurrence of resectable rectal cancer: A single center retrospective study

T1 colorectal cancer management in the era of minimally invasive endoscopic resection

Analysis of risk factors for postoperative recurrence of stage I colorectal cancer: a retrospective analysis of a large population

Pathological Analysis and Therapeutic Evaluation of Early Colorectal Carcinoma Treated by Endoscopic Resection or Surgery

S665 Evaluating Risk Factors for Lymph Node Metastasis in Surgically Resected T1b Esophageal Adenocarcinom

Factors associated with endoscopic treatment decisions for T1b or more deeply invading colorectal cancers

Long-term outcomes after endoscopic versus surgical resection of T1 colorectal carcinoma

Influence of early colorectal cancer component on the positive margins after endoscopic resection: a retrospective study

Long-Term Survival After Local Excision for T1 Carcinoma of the Rectum

Endoscopic Resection of Stage T1 Colorectal Adenocarcinoma Followed by Surgical Intervention: a Single-center Retrospective Study

Prognostic factors for local recurrence in patients with rectal cancer submitted to neoadjuvant chemoradiotherapy and total mesorectal excision

Association between pathological T1 colorectal cancer with lymphoid follicular replacement and risk of lymph node metastasis

Approaches and considerations in the endoscopic treatment of T1 colorectal cancer

T1 colon cancer in the era of screening: risk factors and treatment

[Predictive Factors for Locally Recurrent Rectal Cancer after Primary Curative Surgery].